0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Post-Traumatic Stress Disorder Therapeutics Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-27M898
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Post Traumatic Stress Disorder Therapeutics Market Insights and Forecast to 2028

Global Post-Traumatic Stress Disorder Therapeutics Market Insights and Forecast to 2028

Code: QYRE-Auto-27M898
Report
January 2022
88 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Post-Traumatic Stress Disorder Therapeutics Market Statistics: 2022-2028

The main treatments for post-traumatic stress disorder (PTSD) are psychological therapies and medication. The global Post-Traumatic Stress Disorder Therapeutics market size is projected to reach US$ 3135.3 million by 2028, from US$ 2410.2 million in 2021, at a CAGR of 3.8% during 2022-2028.

Fully considering the economic change by this health crisis, Antidepressants accounting for % of the Post-Traumatic Stress Disorder Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospitals segment is altered to an % CAGR throughout this forecast period.China Post-Traumatic Stress Disorder Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Post-Traumatic Stress Disorder Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Post-Traumatic Stress Disorder Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Post-Traumatic Stress Disorder Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Post-Traumatic Stress Disorder Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Post-Traumatic Stress Disorder Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Post-Traumatic Stress Disorder Therapeutics market.

Post-Traumatic Stress Disorder Therapeutics Market Scope and Segment

Post-Traumatic Stress Disorder Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Post-Traumatic Stress Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Post-Traumatic Stress Disorder Therapeutics Market by Type

  • Antidepressants
  • Anti-Anxiety Drugs
  • Others

Post-Traumatic Stress Disorder Therapeutics Market by Application

  • Hospitals
  • Clinic
  • Others

Post-Traumatic Stress Disorder Therapeutics Market by Company

  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Otsuka Pharmaceutical Co., Ltd
  • Novartis AG
  • AstraZeneca Plc
  • Azevan Pharmaceuticals, Inc.
  • Bionomics Ltd.
  • Tonix Pharmaceuticals Holding Corp.
  • Apotex, Inc.

Post-Traumatic Stress Disorder Therapeutics Market by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antidepressants
1.2.3 Anti-Anxiety Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Post-Traumatic Stress Disorder Therapeutics Market Perspective (2017-2028)
2.2 Post-Traumatic Stress Disorder Therapeutics Growth Trends by Region
2.2.1 Post-Traumatic Stress Disorder Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Post-Traumatic Stress Disorder Therapeutics Market Dynamics
2.3.1 Post-Traumatic Stress Disorder Therapeutics Industry Trends
2.3.2 Post-Traumatic Stress Disorder Therapeutics Market Drivers
2.3.3 Post-Traumatic Stress Disorder Therapeutics Market Challenges
2.3.4 Post-Traumatic Stress Disorder Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue
3.1.1 Global Top Post-Traumatic Stress Disorder Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Post-Traumatic Stress Disorder Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Post-Traumatic Stress Disorder Therapeutics Revenue
3.4 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio
3.4.1 Global Post-Traumatic Stress Disorder Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Post-Traumatic Stress Disorder Therapeutics Revenue in 2021
3.5 Post-Traumatic Stress Disorder Therapeutics Key Players Head office and Area Served
3.6 Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service
3.7 Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Type
4.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2023-2028)
5 Post-Traumatic Stress Disorder Therapeutics Breakdown Data by Application
5.1 Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size (2017-2028)
6.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
6.2.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2017-2028)
6.3 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
6.3.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2017-2028)
6.4 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country
6.4.1 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size (2017-2028)
7.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type
7.2.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2017-2028)
7.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application
7.3.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2017-2028)
7.4 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country
7.4.1 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type
8.2.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application
8.3.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region
8.4.1 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size (2017-2028)
9.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type
9.2.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application
9.3.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country
9.4.1 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type
10.2.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application
10.3.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country
10.4.1 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.1.4 Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Developments
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Introduction
11.2.4 GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.2.5 GlaxoSmithKline plc Recent Developments
11.3 Otsuka Pharmaceutical Co., Ltd
11.3.1 Otsuka Pharmaceutical Co., Ltd Company Details
11.3.2 Otsuka Pharmaceutical Co., Ltd Business Overview
11.3.3 Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Introduction
11.3.4 Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.3.5 Otsuka Pharmaceutical Co., Ltd Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Post-Traumatic Stress Disorder Therapeutics Introduction
11.4.4 Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 AstraZeneca Plc
11.5.1 AstraZeneca Plc Company Details
11.5.2 AstraZeneca Plc Business Overview
11.5.3 AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Introduction
11.5.4 AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.5.5 AstraZeneca Plc Recent Developments
11.6 Azevan Pharmaceuticals, Inc.
11.6.1 Azevan Pharmaceuticals, Inc. Company Details
11.6.2 Azevan Pharmaceuticals, Inc. Business Overview
11.6.3 Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.6.4 Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.6.5 Azevan Pharmaceuticals, Inc. Recent Developments
11.7 Bionomics Ltd.
11.7.1 Bionomics Ltd. Company Details
11.7.2 Bionomics Ltd. Business Overview
11.7.3 Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Introduction
11.7.4 Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.7.5 Bionomics Ltd. Recent Developments
11.8 Tonix Pharmaceuticals Holding Corp.
11.8.1 Tonix Pharmaceuticals Holding Corp. Company Details
11.8.2 Tonix Pharmaceuticals Holding Corp. Business Overview
11.8.3 Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Introduction
11.8.4 Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.8.5 Tonix Pharmaceuticals Holding Corp. Recent Developments
11.9 Apotex, Inc.
11.9.1 Apotex, Inc. Company Details
11.9.2 Apotex, Inc. Business Overview
11.9.3 Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Introduction
11.9.4 Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
11.9.5 Apotex, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Antidepressants
    Table 3. Key Players of Anti-Anxiety Drugs
    Table 4. Key Players of Others
    Table 5. Global Post-Traumatic Stress Disorder Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region (2023-2028)
    Table 11. Post-Traumatic Stress Disorder Therapeutics Market Trends
    Table 12. Post-Traumatic Stress Disorder Therapeutics Market Drivers
    Table 13. Post-Traumatic Stress Disorder Therapeutics Market Challenges
    Table 14. Post-Traumatic Stress Disorder Therapeutics Market Restraints
    Table 15. Global Post-Traumatic Stress Disorder Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Post-Traumatic Stress Disorder Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2021)
    Table 18. Ranking of Global Top Post-Traumatic Stress Disorder Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Post-Traumatic Stress Disorder Therapeutics Product Solution and Service
    Table 22. Date of Enter into Post-Traumatic Stress Disorder Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Post-Traumatic Stress Disorder Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Post-Traumatic Stress Disorder Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Post-Traumatic Stress Disorder Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Pfizer, Inc. Company Details
    Table 63. Pfizer, Inc. Business Overview
    Table 64. Pfizer, Inc. Post-Traumatic Stress Disorder Therapeutics Product
    Table 65. Pfizer, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Pfizer, Inc. Recent Developments
    Table 67. GlaxoSmithKline plc Company Details
    Table 68. GlaxoSmithKline plc Business Overview
    Table 69. GlaxoSmithKline plc Post-Traumatic Stress Disorder Therapeutics Product
    Table 70. GlaxoSmithKline plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. GlaxoSmithKline plc Recent Developments
    Table 72. Otsuka Pharmaceutical Co., Ltd Company Details
    Table 73. Otsuka Pharmaceutical Co., Ltd Business Overview
    Table 74. Otsuka Pharmaceutical Co., Ltd Post-Traumatic Stress Disorder Therapeutics Product
    Table 75. Otsuka Pharmaceutical Co., Ltd Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Otsuka Pharmaceutical Co., Ltd Recent Developments
    Table 77. Novartis AG Company Details
    Table 78. Novartis AG Business Overview
    Table 79. Novartis AG Post-Traumatic Stress Disorder Therapeutics Product
    Table 80. Novartis AG Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Novartis AG Recent Developments
    Table 82. AstraZeneca Plc Company Details
    Table 83. AstraZeneca Plc Business Overview
    Table 84. AstraZeneca Plc Post-Traumatic Stress Disorder Therapeutics Product
    Table 85. AstraZeneca Plc Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. AstraZeneca Plc Recent Developments
    Table 87. Azevan Pharmaceuticals, Inc. Company Details
    Table 88. Azevan Pharmaceuticals, Inc. Business Overview
    Table 89. Azevan Pharmaceuticals, Inc. Post-Traumatic Stress Disorder Therapeutics Product
    Table 90. Azevan Pharmaceuticals, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Azevan Pharmaceuticals, Inc. Recent Developments
    Table 92. Bionomics Ltd. Company Details
    Table 93. Bionomics Ltd. Business Overview
    Table 94. Bionomics Ltd. Post-Traumatic Stress Disorder Therapeutics Product
    Table 95. Bionomics Ltd. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. Bionomics Ltd. Recent Developments
    Table 97. Tonix Pharmaceuticals Holding Corp. Company Details
    Table 98. Tonix Pharmaceuticals Holding Corp. Business Overview
    Table 99. Tonix Pharmaceuticals Holding Corp. Post-Traumatic Stress Disorder Therapeutics Product
    Table 100. Tonix Pharmaceuticals Holding Corp. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Tonix Pharmaceuticals Holding Corp. Recent Developments
    Table 102. Apotex, Inc. Company Details
    Table 103. Apotex, Inc. Business Overview
    Table 104. Apotex, Inc. Post-Traumatic Stress Disorder Therapeutics Product
    Table 105. Apotex, Inc. Revenue in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. Apotex, Inc. Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Antidepressants Features
    Figure 3. Anti-Anxiety Drugs Features
    Figure 4. Others Features
    Figure 5. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinic Case Studies
    Figure 8. Others Case Studies
    Figure 9. Post-Traumatic Stress Disorder Therapeutics Report Years Considered
    Figure 10. Global Post-Traumatic Stress Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Post-Traumatic Stress Disorder Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Post-Traumatic Stress Disorder Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Post-Traumatic Stress Disorder Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Post-Traumatic Stress Disorder Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Post-Traumatic Stress Disorder Therapeutics Revenue in 2021
    Figure 16. North America Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Post-Traumatic Stress Disorder Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Post-Traumatic Stress Disorder Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Post-Traumatic Stress Disorder Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Post-Traumatic Stress Disorder Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Post-Traumatic Stress Disorder Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Post-Traumatic Stress Disorder Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Post-Traumatic Stress Disorder Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Pfizer, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 56. GlaxoSmithKline plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 57. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 58. Novartis AG Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 59. AstraZeneca Plc Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 60. Azevan Pharmaceuticals, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 61. Bionomics Ltd. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 62. Tonix Pharmaceuticals Holding Corp. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 63. Apotex, Inc. Revenue Growth Rate in Post-Traumatic Stress Disorder Therapeutics Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights Forecast to 2028
Global Aspetic Negative Pressure Pharmaceutical Isolators Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-0T7466
Fri May 13 00:00:00 UTC 2022

Add to Cart

Global Chemical API Market Insights and Forecast to 2028
Global Chemical API Market Insights and Forecast to 2028

Market Analysis and Insights Global Chemical API MarketThe global Chemical API market size is projected to reach US million by 2028 from US million in 2021 at a CAGR of during 20222028.Fully considering the economic change by this health crisis Bulk API accounting for of the Chemical API global market in 2021 is projected to value US million by 2028 growing at a revised CAGR in the postCOVID19 period.

120 Pages
Type: Report
Code: QYRE-Auto-28A10066
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Follitropin Market Insights and Forecast to 2028
Global Follitropin Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-15J5972
Tue May 03 00:00:00 UTC 2022

Add to Cart